Breast International Group

We’re excited to welcome the new and returning members of BIG’s Executive Board, starting 1 July 2025! Thank you to our outgoing members for their incredible dedication and leadership. Together, we continue advancing international breast cancer research. 💗

What an honor to join the Executive Board of @BIGxResearch As someone living with metastatic breast cancer & connected to many patients’ experiences, I’m excited to support research that reflects what truly matters to people dealing with this disease. bigagainstbreastcancer.org/about-big/gove…

Earlier this week, our team attended the first AI in Oncology conference in Paris, led by Prof. Fabrice André. A brilliant exchange on how AI is shaping cancer research and care. Thank you IHU PRISM for an inspiring first edition! #AIinOncology @PrismCenter

💬 Wrapping up an inspiring week at #ASCO25 & the BIG-NCTN Annual Meeting! From 20 years of #BIGNCTN international collaboration to key updates on SOFT/TEXT, ALTTO, TREAT ctDNA & PALLAS. Thank you to all who drive breast cancer research forward! 💗 #BIGAgainstBreastCancer

Proud to see Cancer Trials Ireland Clinical Lead @Seamusoreilly18 among the authors of this significant paper on advancing equitable access to breast cancer innovation. A timely contribution to global clinical trial reform: rdcu.be/ev9HQ @Nature_NPJ @BIGxResearch…

🤔How can we ⬆️ access to innovation for ALL 🌎🌍🌏patients with #breastcancer @BIGxResearch 📝 @Nature_NPJ Free access link 👉rdcu.be/ev9HQ Successes of the past ✅ Pitfalls of the present ✅ Solutions for the future eg @Path4Young✅ 🙏to co-✍️& funders 💶

📢 New open-access article in npj Breast Cancer, co-authored by BIG’s leadership, explores the challenges of academic clinical trials and how to ensure their future impact. 📄 Read more: nature.com/articles/s4152… #BIGAgainstBreastCancer #breastcancer #research @Nature_NPJ

We’re proud to see our Clinical Lead, @Seamusoreilly18, continuing on the Executive Board of @BIGxResearch - the world’s largest network of academic breast cancer research groups. His leadership reflects CTI's strong commitment to international collaboration and patient-focused…

Looking forward to giving my contribution together with giants in the field of #BreastCancer…grateful for this opportunity! @UniGenova @BIGxResearch @OncoAlert @EuropaDonnaEUR

Os compartimos el 'Informe Anual 2024' del grupo @BIGxResearch, una edición especial por su 25º aniversario que realiza un recorrido por los principales avances en la #investigación del #cáncerdemama y la colaboración internacional en este ámbito 🤝🏼 📑 En las páginas 76-77…

We’re proud to share BIG’s 2024 Annual Report. This special 25th anniversary edition highlights a year of progress in breast cancer research. From key trials to global collaboration, see what we’ve achieved together. 📖 Read: bigagainstbreastcancer.org/wp-content/upl…

For the 5th year in a row, our employees have joined forces in a challenge to support the #FightAgainstCancer. Over the course of 50 days, we took part in various sports activities and rose €35,000 for @BIGxResearch , a charity dedicated to breast cancer research.

Our Scientific Advisor, Thayane Crestani, is attending the @EORTC Course on Clinical Trial Statistics for Non-Statisticians in Brussels, strengthening our team’s expertise to support better clinical research in breast cancer, from study design to data interpretation. 💡📊 📈

📣#ASCO25 distilled by @cancertrials_ie hosted ISMO ☘️ webinar: Top 3 abstracts 📃 by tumor type✅ Single slide summaries of practice 🩻changing developments ✅ Insights from @NEJM authors ✅ Trainee abroad 🍁 perspective ✅ Join Us 👇

At #WorldCancerSeries Europe, Virginie Adam stressed the need to involve patients early in breast cancer trials. She joined Fatima Cardoso & others to discuss equity, access & policy in women-centric care. Thanks @EconomistImpact & @daiichisankyo for the vital conversation.

Our BIG team is attending the 10th annual World Cancer Series Europe in Brussels. They are engaging with global experts to advance breast cancer research and improve patient outcomes. @EconomistEvents

We are thrilled to announce a new collaboration with @paige_ai, leaders in AI-driven cancer digital pathology. Our partnership aims to combine BIG’s clinical trial expertise & data w Paige's AI capabilities to revolutionize #breastcancer research & care 🔗 bit.ly/4kzSsBd

Finding the answer isn’t always easy. Sometimes, one question takes 20 years. Thank you to the 5738 women, families, clinicians, and teams behind SOFT & TEXT. Your courage built our knowledge. And gave others more time. #BreastCancer #ClinicalTrials #Oncology #Hope #Equity @ASCO…

🧬 BIG’s Scientific Director, Virginie Adam, spoke to RTBF about the results from #SERENA-6 presented at #ASCO25. A blood test to detect molecular recurrence + new treatment cut the risk of progression by 56%! 📖 Read more (in FR): rtbf.be/article/cancer…

#SOFT&TEXT trials are the result of over 20 years of collaboration. Thank you to patients and their families, HC providers, study chairs and committees, collaborators, the cross-Atlantic groups & the funders. @etop_ibcsg @theNCI @BCRFcure #ASCO25